Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Schultz

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2007
Interfractional variations in patient setup and anatomic change assessed by daily computed tomographyX Allen Li, X Sharon Qi, Marissa Pitterle, et al.
Cureus|July 2, 2019
Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate CancerJoshua W Lorenz, Diane Schott, Lisa Rein, et al.
Practical Radiation Oncology|November 7, 2021
Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation TherapyEmily H Bero, Lisa E Rein, Anjishnu Banerjee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancerM Tracy Zundel, Michelle A Michel, Christopher J Schultz, et al.
Advances in Radiation Oncology|May 8, 2023
Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in OncologyRachael L Conger, Javier Mora, Michael W Straza, et al.
Biomarker Research|November 21, 2013
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)Andra V Krauze, Minhee Won, Christian Graves, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2020
Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival OutcomesJoseph A Bovi, Melissa A Prah, Amber A Retzlaff, et al.
Advances in Radiation Oncology|January 23, 2024
Cystic Brain Metastasis Outcomes After Gamma Knife Radiation TherapyRyan F Amidon, Katie Livingston, Christopher J Kleefisch, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocolLuis Souhami, Wendy Seiferheld, David Brachman, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2007
Interfractional variations in patient setup and anatomic change assessed by daily computed tomographyX Allen Li, X Sharon Qi, Marissa Pitterle, et al.
Cureus|July 2, 2019
Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate CancerJoshua W Lorenz, Diane Schott, Lisa Rein, et al.
Practical Radiation Oncology|November 7, 2021
Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation TherapyEmily H Bero, Lisa E Rein, Anjishnu Banerjee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancerM Tracy Zundel, Michelle A Michel, Christopher J Schultz, et al.
Advances in Radiation Oncology|May 8, 2023
Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in OncologyRachael L Conger, Javier Mora, Michael W Straza, et al.
Biomarker Research|November 21, 2013
Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)Andra V Krauze, Minhee Won, Christian Graves, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2020
Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival OutcomesJoseph A Bovi, Melissa A Prah, Amber A Retzlaff, et al.
Advances in Radiation Oncology|January 23, 2024
Cystic Brain Metastasis Outcomes After Gamma Knife Radiation TherapyRyan F Amidon, Katie Livingston, Christopher J Kleefisch, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2004
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocolLuis Souhami, Wendy Seiferheld, David Brachman, et al.
Pageof 7